Fulgent Genetics downgraded to market perform from outperform at Raymond James Nov. 7, 2017 at 8:25 a.m. ETby Tomi Kilgore Fulgent Genetics started at outperform with $13 stock price target at Credit Suisse Oct. 24, 2016 at 9:21 a.m. ETby Tomi Kilgore ...
View Fulgent Genetics (FLGT) stock price, news, historical charts, analyst ratings, financial information and quotes on Futubull. Trade commission-free with the Futubull stock trading app.
Price Target $30.00 Fulgent Genetics MarketRank™ Stock Analysis Analyst Rating Hold 2.00 Rating Score Upside/Downside 44.4% Upside $30.00 Price Target Short Interest Healthy 3.02% of Float Sold Short Dividend Strength N/A Sustainability
Current Price $8.65 OTC: EXETF Extendicare Market Cap $567M Current Price $6.79 TSX: KSI Kneat.com, Inc. Market Cap CA$444M Current Price CA$4.75 Premium Investing Services Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's ...
Fulgent Genetics (NASDAQ:FLGT) said Monday it acquired Fulgent Pharma, an independent clinical-stage pharmaceutical firm, for ~$100M. The deal amount will be paid with cash on hand and Fulgent Genetics' (FLGT) stock. The combined firm plans to offer a vertically integrated solution Share...
Stay up-to-date on Fulgent Genetics, Inc. Common Stock (FLGT) Dividends, Current Yield, Historical Dividend Performance, and Payment Schedule.